These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 10669994)
1. Circulating pro- and antioxidant factors in iron and porphyrin metabolism disorders. Rocchi E; Casalgrandi G; Masini A; Giovannini F; Ceccarelli D; Ferrali M; Marchini S; Ventura E Ital J Gastroenterol Hepatol; 1999 Dec; 31(9):861-7. PubMed ID: 10669994 [TBL] [Abstract][Full Text] [Related]
2. Effects of vitamin E administration on the hemorheological status and redox homeostasis of patients with porphyria cutanea tarda treated with phlebotomy. Székely E; Vereckei A; Almási A; Rapavi E; Tasnádi G; Várnai K; Pallai Z; Lugasi A; Blázovics A Clin Hemorheol Microcirc; 2007; 36(1):13-23. PubMed ID: 17211058 [TBL] [Abstract][Full Text] [Related]
3. [Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda]. Malina L; Zd'árský E; Dandová S; Michalíková H; Cerná M; Cimburová M Cas Lek Cesk; 2000 Nov; 139(23):728-30. PubMed ID: 11191743 [TBL] [Abstract][Full Text] [Related]
4. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron. Siersema PD; Rademakers LH; Cleton MI; ten Kate FJ; de Bruijn WC; Marx JJ; Wilson JH J Hepatol; 1995 Sep; 23(3):259-67. PubMed ID: 8550989 [TBL] [Abstract][Full Text] [Related]
5. Hemorheological status and redox homeostasis of phlebotomised porphyria cutanea tarda patients with diabetes mellitus and in moderate alcohol consumer. Székely E; Bor M; Tasnádi G; Várnai K; Almási A; Blázovics A Clin Hemorheol Microcirc; 2006; 35(3):387-96. PubMed ID: 16899961 [TBL] [Abstract][Full Text] [Related]
6. Cascade testing of primary care blood samples with hyperferritinaemia identifies subjects with iron overload and porphyria cutanea tarda. Baddams EL; Degg T; Barth JH Ann Clin Biochem; 2014 Jul; 51(Pt 4):499-502. PubMed ID: 24081184 [TBL] [Abstract][Full Text] [Related]
7. Influence of hepatitis C virus (HCV) infection on porphyrin and iron metabolism in porphyria cutanea tarda (PCT) patients. Dabrowska E; Jabłońska-Kaszewska I; Bielawski KP; Falkiewicz B Med Sci Monit; 2001 May; 7 Suppl 1():190-6. PubMed ID: 12211718 [TBL] [Abstract][Full Text] [Related]
8. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Roberts AG; Whatley SD; Morgan RR; Worwood M; Elder GH Lancet; 1997 Feb; 349(9048):321-3. PubMed ID: 9024376 [TBL] [Abstract][Full Text] [Related]
16. [Study of the gene of hemochromatosis in first degree relatives of patient with porphyria cutanea tarda]. García-Morillo JS; Carneado de la Fuente J; Stiefel García-Junco P; García-Donas MA; González Escribano MF; Núñez-Roldán A Med Clin (Barc); 1999 May; 112(18):699-701. PubMed ID: 10374203 [TBL] [Abstract][Full Text] [Related]
17. Porphyria cutanea tarda in a Swedish population: risk factors and complications. Rossmann-Ringdahl I; Olsson R Acta Derm Venereol; 2005; 85(4):337-41. PubMed ID: 16191856 [TBL] [Abstract][Full Text] [Related]
18. Correlation between levels of free and protein-bound plasma porphyrin and urinary porphyrins in porphyria cutanea tarda. Moran MJ; Fontanellas A; Santos JL; Enriquez de Salamanca R Int J Biochem Cell Biol; 1995 Jun; 27(6):585-8. PubMed ID: 7671136 [TBL] [Abstract][Full Text] [Related]
19. Porphyrins, porphyrin metabolism, porphyrias. III. Diagnosis, care and monitoring in porphyria cutanea tarda--suggestions for a handling programme. Thunell S; Harper P Scand J Clin Lab Invest; 2000 Nov; 60(7):561-79. PubMed ID: 11202050 [TBL] [Abstract][Full Text] [Related]
20. The frequency of hemochromatosis-associated alleles is increased in British patients with sporadic porphyria cutanea tarda. Roberts AG; Whatley SD; Nicklin S; Worwood M; Pointon JJ; Stone C; Elder GH Hepatology; 1997 Jan; 25(1):159-61. PubMed ID: 8985283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]